<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: Accurate <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> classification is critical for meaningful epidemiological studies in the assessment of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> incidence rates and trends </plain></SENT>
<SENT sid="1" pm="."><plain>Differentiating primary gastric <z:mp ids='MP_0002038'>carcinoma</z:mp> from oesophageal <z:mp ids='MP_0002038'>carcinoma</z:mp> can be difficult, especially when <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> are large and involve both the oesophagus and stomach </plain></SENT>
<SENT sid="2" pm="."><plain>Furthermore, <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> of both organs typically are of intestinal histological type and arise in a background of <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> </plain></SENT>
<SENT sid="3" pm="."><plain>Consequently, histological markers that reliably distinguish Barrett's-related oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> from <z:mp ids='MP_0008010'>gastric adenocarcinoma</z:mp> would be useful </plain></SENT>
<SENT sid="4" pm="."><plain>Cytokeratins (CK)7 and 20 are cytoplasmic structural proteins with restricted expression that help to determine the origin of many <z:e sem="disease" ids="C0205853" disease_type="Neoplastic Process" abbrv="">epithelial tumours</z:e> including those of the gastrointestinal tract </plain></SENT>
<SENT sid="5" pm="."><plain>The aim of this study was to determine the utility of co-ordinate CK7 and 20 expression in the distinction of Barrett's-related oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> from <z:mp ids='MP_0008010'>gastric adenocarcinoma</z:mp> arising in a background of <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> </plain></SENT>
<SENT sid="6" pm="."><plain>METHODS AND RESULTS: CK7 and 20 immunostaining was performed on randomly selected surgical resection specimens from patients with Barrett's-related oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (n = 30) and intestinal type <z:mp ids='MP_0008010'>gastric adenocarcinoma</z:mp> (n = 14) arising in a background of <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> </plain></SENT>
<SENT sid="7" pm="."><plain>A CK7+ CK20- immunophenotype was demonstrated in 27 of 30 (90%) patients with Barrett's-related oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> and only three of 14 (21%) <z:mp ids='MP_0008010'>gastric adenocarcinomas</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>The sensitivity, specificity and positive predictive value of a CK7+/20- immunophenotype for a diagnosis of Barrett's-related oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> was 90%, 79%, and 90%, respectively </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: A CK7+/20- <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> immunophenotype is associated with Barrett's-related oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> and may be useful in accurate <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> classification, thus facilitating improving epidemiological evaluation of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> at the oesophagogastric junction </plain></SENT>
</text></document>